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INTRODUCTION
Anemia is one of the most common hematologic manifes-
tations in patients with malignant lymphomas. There are
many potential causes, including: chemotherapy-induced
myelosuppression, anemia of chronic disease associated with
treatment or disease-related morbidity, autoimmune hemo-
lytic anemia, iron deficiency, and neoplastic infiltration of
bone marrow. Recently, it was reported that a hemoglobin
less than 10 g/dL may be a finding predictive of bone marrow
involvement in patients with diffuse large B cell lymphoma
(1). Because it is not uncommon to find lymphoma cell infil-
tation in bone marrow, anemia should be thoroughly evalu-
ated especially when it is found in patients with recurrent
non-Hodgkin’s lymphoma. However, since the causes of
anemia are not always related to lymphoma-related mani-
festations, other possible causes of anemia must be evaluat-
ed especially when the findings of anemia are isolated with-
out any other hematologic findings. 
Pure red cell aplasia (PRCA) is a rare hematological con-
dition characterized by an isolated anemia, normocytic nor-
mochromic, with reticulocytopenia and erythroid hypoplasia
of the bone marrow with normal megakaryocytic and myeloid
cell lineages. Although this condition rarely occurs in non-
thymic lymphoproliferative disorders, a few cases of PRCA
have been reported in patients with diffuse large B cell lym-
phoma. Most reported cases are due to parvovirus B19 infec-
tion after stem cell transplantation or monoclonal antibody
treatment (2-5). These cases of infection might be associated
with a compromised immune system as a result of treatments.
However, latent Epstein-Barr virus (EBV) infection-induced
PRCA is uncommon and it has never been reported in a pa-
tient with non-Hodgkin’s lymphoma. Herein, we report a
case of PRCA, which was initially suspected to be a result of
bone marrow involvement of diffuse large B cell lymphoma.
CASE REPORT
A 43-yr-old male patient was admitted to our hospital
because of painless cervical lymph node enlargement in 2000.
He was diagnosed with diffuse large B cell lymphoma by
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Persistent Anemia in a Patient with Diffuse Large B Cell Lymphoma:
Pure Red Cell Aplasia Associated with Latent Epstein-Barr Virus
Infection in Bone Marrow
We report a case of pure red cell aplasia (PRCA), which was initially suspected as
a result of bone marrow involvement of diffuse large B cell lymphoma. Persistent
anemia without an obvious cause was observed in a 47-yr-old man diagnosed with
relapsed diffuse large B cell lymphoma. The bone marrow study showed only ery-
throid hypoplasia without the evidence of bone marrow involvement with lymphoma
cells, thus PRCA was suggested. However, parvovirus infection was excluded as a
potential cause of PRCA because of negative IgM anti-parvovirus B19 antibody
and negative parvovirus PCR in the serum. Latent Epstein-Barr virus (EBV) infec-
tion of bone marrow was suggested by in situ hybridization with EBV-encoded small
RNA (EBER) that showed a strong positive expression in bone marrow cells. Thus,
PRCA was thought to be associated with latent EBV infection in bone marrow cells.
Although the finding of unexplained anemia is a possible predictor of bone marrow
involvement with lymphoma cells, PRCA as a result of a viral infection including
EBV should be considered in lymphoma patients. This is the first report of the occu-
rrence of PRCA associated with latent EBV infection in a patient with non-Hodgkin’s
lymphoma.
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evaluations of excisional biopsy of cervical lymph nodes. He
was staged as IIA according to the Ann Arbor staging sys-
tem, and bone marrow aspirates and biopsy revealed absence
of lymphoma cell infiltration. The patient achieved complete
remission with CEOP-B chemotherapy (cyclophosphamide,
epirubicin, oncovin, prednisone, and bleomycin). The patient
was readmitted to our hospital because of a painless mass in
his right supraclavicular region on 12 November 2004.
Chest computerized tomography (CT) scan showed a 2×3
cm-sized lymph node enlargement in the right supraclavic-
ular fossa. In addition, multiple lymph nodes in the right
upper mediastinum were observed, which these had not been
observed in previous CT scans. Multiple lymph node enlarge-
ments of mesentery and left para-aortic areas were also found
on the abdomino-pelvic CT scan. Recurrence of diffuse large
B cell lymphoma was confirmed by biopsy of a supraclavic-
ular lymph node. Serum LDH and beta-2 microglobulin
were elevated up to 507 IU/L and 3.60 mg/L, respectively.
Other laboratory studies on admission were within normal
ranges except complete blood cell (CBC) counts that showed:
hemoglobin 9.7 g/dL (which was 14.1 g/dL 3 months before),
reticulocyte 2,600/mL, MCV 103 fl, leukocytes 5.74×109/L,
and platelets 326×109/L. Serum vitamin B12, folate, hap-
toglobin and ferritin levels were within normal ranges; how-
ever, serum erythropoietin was elevated at 71.7 mU/mL (nor-
mal, 10.2-25.2). There was no evidence of internal bleeding
such as gastrointestinal bleeding or autoimmune hemolytic
anemia. The Coomb’s test was negative. To exclude the pos-
sibility of bone marrow infiltration by lymphoma cells, bone
marrow aspiration and biopsy were performed on bilateral
iliac crest. However, severe paucity of erythroid cells with
intact myeloid and megakaryocytic lineages was observed
(Fig. 1), and there was no neoplastic cell infiltration in the
marrow (Fig. 2). Thus, we suspected anemia associated with
other causes including PRCA associated with viral infection
especially parvovirus B19. However, there was no evidence
supporting parvovirus infection. Laboratory findings revealed
negative anti-parvovirus B19 IgM antibody in serum and
Fig. 3. In situ hybridization with Epstein-Barr virus (EBV)-encoded
small RNA (EBER) showed positive expression in bone marrow
cells, which suggested latent EBV infection in bone marrow.
Fig. 2. Bone marrow biopsy section (Hematoxylin & eosin stain, ×
100). Marrow cellularity is decrased; however, there was no evi-
dence of marrow infiltration of lymphoma cells.
Fig. 1. Bone marrow aspirate smear (Wright-Giemsa stain, ×400).
Marrow cellularity is decreased for the patient’s age and severe
paucity of erythroid cells is observed. However, myeloid and me-
gakaryocytic lineage is intact. negative parvovirus B19 DNA in polymerase chain reaction
with the patient’s blood samples. Serological investigations
for an acute infection for cytomegalovirus, hepatitis-A, -B
and -C virus were all negative. However, we found that IgG
antibody against EBV (EBNA) was positive, although the
heterophil antibody and EBV VCA IgM antibody were neg-
ative in the patient’s serum. Thus, we performed in situ hy-
bridization with EBV-encoded small RNA (EBER) in a bone
marrow section from the patient and found a positive expres-
sion of EBER in the bone marrow cells, which suggested
latent EBV infection in bone marrow (Fig. 3). During two
cycles of salvage chemotherapy, the CBC findings showed
severe persistent hematologic toxicity confined to anemia;
the hemoglobin level was around 4.5 g/dL for several months
even after the completion of chemotherapy; however, leuko-
cyte and platelet counts recovered to the normal ranges. After
salvage chemotherapy, the patient achieved complete remis-
sion again; however, the anemia persisted and required repeat-
ed red blood cell transfusions.
DISCUSSION
Acquired PRCA has a variety of causes. Viral infection is
a common cause of PRCA. Among viruses capable of sup-
pressing erythropoiesis, human parvovirus B19 is well-rep-
resented. This DNA virus infects erythrocytes by binding
to the P antigen on the cell membranes resulting in suppres-
sion of erythropoiesis. However, the virus does not attach to
the myeloid cells. Suppressed erythropoiesis is transient in
healthy hosts who spontaneously recover in a short period of
time. However, the suppression of erythropoiesis can persist,
leading to PRCA owing to persistent viremia in immune-
compromised individuals such as patients with HIV, sarcoi-
dosis, and hematologic malignancy, transplant recipients,
and patients treated with chemotherapy or immunosuppre-
sive agents. There have been a few case reports of parvovirus
B19 infection-induced PRCA in patients with B-cell lym-
phoma receiving anti-CD20 monoclonal antibody rituximab
(3, 6). This might be related to compromised humoral im-
munity by B-lymphocyte depletion. PRCA has also been
reported to present as an initial manifestation unrelated to
treatment in many types of lymphoma (7-10). Co-existence
of autoimmune hemolytic anemia and PRCA in malignant
lymphoma has also been reported (11-13). Because malig-
nant lymphoma is often associated with immunological dis-
orders such as hemolytic anemia, it is conceivable that warm
autoantibody against red blood cells may damage erythroid
progenitors resulting in PRCA (14).
However, our case had no evidence of parvovirus B19 infec-
tion or hemolytic anemia. Bone marrow invasion by lym-
phoma was suspected in our case. However, there was no
evidence of bone marrow involvement of diffuse large B cell
lymphoma. In situ hybridization with EBER in bone mar-
row suggests occult bone marrow invasion as has been pre-
viously reported in a case of extranodal NK/T cell lymphoma
(15). However, there is no prior report of positive EBER in
situ hybridization as a marker for occult bone marrow involve-
ment of diffuse large B cell lymphoma as in extranodal NK/
T cell lymphoma. Therefore, it is unlikely that an occult
bone marrow involvement resulted in PRCA in our case.
Occurrence of PRCA in non-Hodgkin’s lymphoma is also
reported to be associated with the presence of inhibitory fac-
tors in the serum, which suppress erythropoiesis in the bone
marrow (16). The association of serum IgG inhibitor of bone
marrow progenitor cells with the development of PRCA has
been reported in patients with follicular small cleaved B cell
lymphoma (17). These inhibitory factors might be related
to the underlying disease, lymphoma. However, an exact
causal relationship remains to be defined.
In our case, EBV infection was suggested as a cause of
PRCA based on the results of in situ hybridization with
EBER. EBV is also known to be a cause of PRCA, although
it is not as common as parvovirus B19. In a case report of
PRCA associated with chronic EBV infection, in vitro cul-
ture of bone marrow cells from a patient and a healthy con-
trol showed that the formation of erythroid colony forming
(ECF) units from the patient were reduced by 50% com-
pared to the healthy control (18). However, T-cell depletion
from the patient’s bone marrow culture resulted in a three-
fold increase in ECF units. Thus, the findings in this study
suggested that PRCA-associated with chronic EBV infec-
tion might be related to T-cell mediated suppression of ECF
unit proliferation in the bone marrow milieu. EBV usually
infects B-lymphocytes via the CD21 receptor. However, there
is no active viral replication and the host cells are not killed.
Thus, EBV-infected B cells can become immortalized lead-
ing to latent EBV infection of the B cell. In situ hybridiza-
tion with EBER in bone marrow section can localize EBV-
infected cells and detect latent EBV infection with a high
degree of accuracy (19, 20). Thus, positive EBER expression
in bone marrow cells of our case demonstrated latent EBV
infection of bone marrow cells and this is suggested as a pos-
sible cause of PRCA.
In conclusion, although persistent anemia is a possible pre-
dictor of bone marrow involvement with lymphoma cells,
PRCA should be considered in lymphoma patients. Further-
more, when there is no evidence supporting parvovirus B19
infection as a cause of PRCA, the presence of EBV infection
should be evaluated. This is the first report of the occurrence
of PRCA associated with latent EBV infection in a patient
with recurrent diffuse large B cell lymphoma.
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